Clinical Trials Logo

Filter by:
NCT ID: NCT00901641 Active, not recruiting - Insomnia Clinical Trials

Computer-Based Cognitive Training and Sleep Quality in Older Adult Insomniacs

Start date: May 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of computerized, home-based cognitive training on sleep quality of older adults with insomnia.

NCT ID: NCT00901433 Completed - Asthma Clinical Trials

Self Operating of the Personal WheezoMeter by Intended Users - A Usability Study

Start date: January 2009
Phase: N/A
Study type: Observational

The NAEPP (National Asthma Education and Prevention Program) guidelines recommend that spirometry be performed on patients with asthma because they serve as an objective measure of airway obstruction. Unfortunately, most children under 5 years of age are unable to perform a forced expiratory maneuver making conventional spirometry unavailable in this age group in most venues. Furthermore, other population groups such as retarded people, elderly or physically handicapped share the same difficulty. Karmel Sonix Ltd has developed the Personal WheezoMeter a hand-held pulmonary sounds analyzer that utilizes contact sensors to acquire, amplify, filter, record and quantify the presence of wheezing. This usability study was designed to test independent home use and device interface effectiveness of the Personal WheezoMeter in order to validate its safe and effective use by intended users.

NCT ID: NCT00901056 Completed - Clinical trials for Erectile Dysfunction

Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction

Start date: November 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Low intensity shockwaves have been proven in animal studies to induce local growth of new blood vessels from existing ones. The hypothesis of this study is that shockwave therapy could improve the symptoms of patients with erectile dysfunction resulted from a vascular origin and respond to PDE-5 inhibitors.

NCT ID: NCT00900731 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

INTENSITY
Start date: June 2009
Phase: Phase 3
Study type: Interventional

This study compared the lung effects of indacaterol to those of tiotropium in patients with moderate to severe chronic obstructive pulmonary disease (COPD) over a 12 week period.

NCT ID: NCT00899561 Recruiting - Clinical trials for Chronic Rhinosinusitis

Computed Tomography (CT) Score and Histopathology of the Middle Turbinate in Chronic Rhinosinusitis

CT
Start date: December 2008
Phase: N/A
Study type: Observational

In a previous study (Berger el al. Old and new aspects of middle turbinate histopathology. Otolaryngol Head Neck Surg. 2009;140:48-54), the investigators reported significant histopathologic changes in the middle turbinate mucosa of patients with chronic rhinosinusitis compared with normal controls. However, patients' mean Lund-MacKay CT score was 6.5±6.7 and were considered as having a relatively limited sinus disease (a score of 1-8). Nine to sixteen was considered as intermediate sinus disease, and 17-24 extensive. No osteomyelitic changes were seen in this study group. The investigators hypothesize that a comparison between the three groups of patients with chronic rhinosinusitis having limited, intermediate, and extensive sinus disease would show that the higher the CT staging, the greater the histopathologic changes of the middle turbinate. The investigators also expect to find osteomyelitic changes in the middle turbinate of patients with higher CT staging.

NCT ID: NCT00898521 Completed - Burn Clinical Trials

Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns

Start date: December 20, 2009
Phase: Phase 2
Study type: Interventional

Burns represent one of the most severe and dreaded traumas. Burned and traumatized tissue is known as eschar. The dead eschar, if not removed, often becomes heavily contaminated and is the source of local and/or systemic infection or sepsis. The local inflammation and infection destroy healthy surrounding tissues and extends the original damage. In order to prevent these complications, and in order to minimize the risk of infection, it is imperative to evaluate the burn and remove all of the offending eschar at the earliest possible opportunity. This removal of dead tissue is termed "debridement". The most direct debridement method for eschar removal is surgery. Traditional, conservative non-surgical debridement is a lengthy process which often involves many complications. The objectives of this study are as follows: 1. To evaluate the safety and efficacy (exploratory) of DGD in hospitalized patients with Partial Thickness (mid and deep dermal) thermal burns of 4-30% total body surface area (TBSA), but with total burn wounds of no more than 30% TBSA. Measures have already been taken in previous studies involving deeper wounds to control safety parameters (such as pain, fever and infection). Nevertheless, as part of the effort to expand the burn population in the future phase 3 study to the more superficial wound group, it is important to first explore these parameters in a small group involving this burn population. 2. To explore DGD absorption as measured by Pharmacokinetic testing.

NCT ID: NCT00898365 Recruiting - Clinical trials for Renal Cell Carcinoma

Study of Kidney Tumors in Younger Patients

Start date: February 27, 2006
Phase:
Study type: Observational

This research trial studies kidney tumors in younger patients. Collecting and storing samples of tumor tissue, blood, and urine from patients with cancer to study in the laboratory may help doctors learn more about changes that occur in deoxyribonucleic acid (DNA) and identify biomarkers related to cancer.

NCT ID: NCT00894881 Not yet recruiting - Healthy Clinical Trials

The Effect of Colonoscopy on Resting Energy Expenditure

Start date: May 2009
Phase: N/A
Study type: Observational

The Effect of Gut Cleaning as a Preparation to Colonoscopy on resting energy expenditure (REE).

NCT ID: NCT00894387 Completed - Clinical trials for Congestive Heart Failure

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure

ASTRONAUT
Start date: May 2009
Phase: Phase 3
Study type: Interventional

This study evaluated the effect of early initiation of aliskiren therapy, compared to standard therapy, in the reduction of cardiovascular death and heart failure re-hospitalization events within 6 months, in congestive heart failure (CHF) patients hospitalized for an episode of acute decompensated heart failure.

NCT ID: NCT00894309 Not yet recruiting - Critically Ill Clinical Trials

Validation of the Fluid Responsiveness Index in Critically Ill Patients

FRI
Start date: May 2009
Phase: N/A
Study type: Observational

Fluid therapy is an important part of the management of patients with hemodynamic instability in the intensive care unit. By increasing cardiac preload, it aims at elevating cardiac output (CO) and thus restoring hemodynamic conditions in patients who are preload responsive. By contrast, volume administration can be deleterious in terms of pulmonary edema formation or other manifestations or fluid overload, especially in patients who are not preload responsive. Functional dynamic parameters that use heart-lung interactions, such as pulse pressure variation (PPV) and stroke volume variation (SVV) are considered accurate predictors of preload responsiveness in patients receiving fully controlled mechanical ventilation. However, in cases of spontaneous breathing activity where heart-lung interaction indices fail to predict fluid responsiveness, one needs parameters able to reliably predict the hemodynamic response of fluid administration. A new index that could indicate fluid responsiveness, so-called the fluid responsiveness index (FRI), has been elaborated. The advantage is that it could be used in patients who are not in control mechanical ventilation as well as in patients who are fully adapted to mechanical ventilation. The FRI is based upon the analysis of continuous arterial and continuous central venous pressure. The FRI is determined by the relation of cardiac and respiratory activity; both are evaluated by means of power spectrum analysis of the pressures recorded. The aim of this study is to test the value of the FRI to predict the hemodynamic response to fluid infusion in patients with hemodynamic instability not receiving fully controlled mechanical ventilation.